In parallel with the amelioration of the cognitive impairment, diabetic brain MDA levels and the mRNA levels of gp91phox, p22phox, and IL-1β were significantly decreased, to non-diabetic control levels (Fig. 5B and C). The gene discussed is CYBB; the disease is Cognitive impairment.